vidarabine phosphate and cytarabine

vidarabine phosphate has been researched along with cytarabine in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	8 (61.54)	18.7374
1990's	2 (15.38)	18.2507
2000's	3 (23.08)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cohen, SS; North, TW	1
Capizzi, RL; Kucera, GL	1
Fridland, A; Verhoef, V	1
Bigner, DD; Friedman, HS; Schold, SC	1
Akiyama, Y; Kubota, M; Mikawa, H; Takimoto, T; Tanizawa, A	1
Gandhi, V; Keating, MJ; Nowak, B; Plunkett, W	1
Gandhi, V; Plunkett, W	1
Arnold, W; Hess, G; Meyer zum Büschenfelde, KH	1
Friedman-Kien, AE; Klein, RJ	1
Bosanquet, AG	1
Akutsu, M; Bai, L; Furukawa, Y; Ichikawa, A; Kano, Y; Kon, K; Suzuki, K; Tsunoda, S	1
Child, JA; Johnson, PW; Johnson, SA; Morgan, GJ; Prentice, AG; Rule, S; Smith, GM; Tollerfield, SM; Wareham, E	1
Avramis, IA; Avramis, VI; Laug, WE; Sausville, EA	1

Reviews

1 review(s) available for vidarabine phosphate and cytarabine

Article	Year
Aranucleosides and aranucleotides in viral chemotherapy. Pharmacology & therapeutics, 1979, Volume: 4, Issue:1 Topics: Animals; Arabinonucleosides; Arabinonucleotides; Cytarabine; Guanine; Herpesviridae; Herpesviridae Infections; Humans; Hypoxanthines; Thymine; Vidarabine; Vidarabine Phosphate; Virus Diseases; Virus Replication	1979

Trials

1 trial(s) available for vidarabine phosphate and cytarabine

Article	Year
FLUDAP: salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma. Leukemia & lymphoma, 2000, Volume: 37, Issue:3-4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Recurrence; Salvage Therapy; Survival Rate; Vidarabine Phosphate	2000

Other Studies

11 other study(ies) available for vidarabine phosphate and cytarabine

Article	Year
1-beta-D-arabinofuranosylcytosine-diphosphate-choline is formed by the reversal of cholinephosphotransferase and not via cytidylyltransferase. Cancer research, 1992, Jul-15, Volume: 52, Issue:14 Topics: Animals; Choline-Phosphate Cytidylyltransferase; Cytarabine; Cytidine Diphosphate Choline; Diacylglycerol Cholinephosphotransferase; Leukemia L5178; Nucleotidyltransferases; Vidarabine Phosphate	1992
Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts. Cancer research, 1985, Volume: 45, Issue:8 Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleosides; B-Lymphocytes; Cell Line; Cell Survival; Cytarabine; Deoxyguanosine; Humans; Leukemia; Phosphorylation; T-Lymphocytes; Vidarabine; Vidarabine Phosphate	1985
Chemotherapy of subcutaneous and intracranial human medulloblastoma xenografts in athymic nude mice. Cancer research, 1986, Volume: 46, Issue:1 Topics: Animals; Azacitidine; Brain Neoplasms; Cell Line; Cytarabine; Doxorubicin; Humans; Medulloblastoma; Melphalan; Mice; Mice, Nude; Mitoguazone; Neoplasm Transplantation; Nitrosourea Compounds; Skin Neoplasms; Vidarabine Phosphate	1986
Differential modulation of 1-beta-D-arabinofuranosylcytosine metabolism by hydroxyurea in human leukemic cell lines. Biochemical pharmacology, 1988, May-01, Volume: 37, Issue:9 Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; B-Lymphocytes; Cell Line; Cytarabine; Deoxyadenine Nucleotides; Deoxyadenosines; Deoxycytidine; Deoxycytosine Nucleotides; Humans; Hydroxyurea; Leukemia; T-Lymphocytes; Thymine Nucleotides; Vidarabine Phosphate	1988
Modulation of arabinosylcytosine metabolism by arabinosyl-2-fluoroadenine in lymphocytes from patients with chronic lymphocytic leukemia: implications for combination therapy. Blood, 1989, Nov-01, Volume: 74, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cytarabine; Drug Evaluation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Vidarabine Phosphate	1989
Interaction of arabinosyl nucleotides in K562 human leukemia cells. Biochemical pharmacology, 1989, Oct-15, Volume: 38, Issue:20 Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleosides; Arabinonucleotides; Cytarabine; Deoxyribonucleotides; Drug Interactions; Guanosine Triphosphate; Humans; Leukemia; Phosphorylation; Phosphotransferases; Tumor Cells, Cultured; Vidarabine; Vidarabine Phosphate	1989
Inhibition of hepatitis B virus deoxyribonucleic acid polymerase by the 5'-triphosphates of 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine. Antimicrobial agents and chemotherapy, 1981, Volume: 19, Issue:1 Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cytarabine; Hepatitis B virus; Nucleic Acid Synthesis Inhibitors; Time Factors; Vidarabine; Vidarabine Phosphate	1981
Effect of eight antiviral drugs on the reactivation of herpes simplex virus in explant cultures of latently infected mouse trigeminal ganglia. The Journal of investigative dermatology, 1984, Volume: 83, Issue:5 Topics: Acyclovir; Animals; Antibodies, Viral; Antiviral Agents; Arabinofuranosyluracil; Arabinonucleosides; Bromodeoxyuridine; Culture Media; Culture Techniques; Cytarabine; Foscarnet; Mice; Mice, Hairless; Neutralization Tests; Phosphonoacetic Acid; Simplexvirus; Thymidine; Trigeminal Nerve; Vidarabine Phosphate; Virus Activation	1984
Re: V.I. Avramis et al., Pharmacokinetic and pharmacodynamic studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusions after a Phase I/II study in pediatric patients with relapsed leukemias. Clin. Can Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytarabine; Humans; Leukemia; Terminology as Topic; Vidarabine; Vidarabine Phosphate	1999
In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis. Leukemia, 2000, Volume: 14, Issue:3 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Survival; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Humans; Hydroxyurea; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Methotrexate; Neoplastic Stem Cells; Tumor Cells, Cultured; Vidarabine; Vidarabine Phosphate; Vincristine	2000
Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines. Cancer chemotherapy and pharmacology, 2003, Volume: 52, Issue:4 Topics: Adamantane; Antimetabolites, Antineoplastic; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cytarabine; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Humans; Hydroquinones; Imatinib Mesylate; Leukemia-Lymphoma, Adult T-Cell; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Vascular Endothelial Growth Factor A; Vidarabine Phosphate	2003